Literature DB >> 2748865

Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration.

B Söderpalm1, E Eriksson, J A Engel.   

Abstract

1. The anticonflict and the rotarod impairing effects of the triazolo-benzodiazepine alprazolam (APZ) and the conventional 1,4-benzodiazepine (BDZ) diazepam (DIZ) were studied in the rat. 2. After acute administration the two drugs displayed approximately equal potency with respect to anticonflict effects in Vogel's conflict test and in Montgomery's conflict test. The results obtained in the former model indicate that also the efficacies of the two drugs are approximately equal. The shapes of the dose response curves obtained in this model differed, however, markedly. Thus, while APZ displayed a wide high efficacy dose-range (0.5-16.0 mg/kg), a maximal effect of DIZ was obtained in a narrow dose-range only (around 4.0 mg/kg). 3. Acutely, APZ was more rotarod impairing than DIZ; total impairment after 2.0 mg/kg of APZ and 3.5 mg/kg of DIZ. 4. After daily treatment with doses producing approximately equal and close to maximal anticonflict effects (APZ 1.25 mg/kg/day; DIZ 3.0 mg/kg/day) tolerance developed to the rotarod impairing (6 days of treatment) and the anticonflict (Vogel's conflict test; 9 days of treatment) effects of both drugs. It appeared, however, as if tolerance was more pronounced to the ataxic/sedative effects (approximately a four-fold rightward shift of the dose-response curve) than to the anticonflict effect (approximately a two-fold shift) of APZ, whereas tolerance developed to about the same extent to the two effects of DIZ (approximately two-fold shifts). 5. In conclusion, for APZ, but not for DIZ, after long-term administration of a dose producing marked anxiolytic-like effects, the relationship anxiolytic-like effect vs. ataxic/sedative effects was altered. These findings offer a tentative explanation to the putative advantage of APZ over conventional BDZs in the treatment of panic disorder.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2748865     DOI: 10.1016/0278-5846(89)90024-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models.

Authors:  M Heilig; B Söderpalm; J A Engel; E Widerlöv
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Alpha 1- and beta-adrenoceptor stimulation potentiate the anticonflict effect of a benzodiazepine.

Authors:  B Söderpalm; J A Engel
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Alpha 2-adrenoceptor antagonists potentiate the anticonflict and the rotarod impairing effects of benzodiazepines.

Authors:  B Söderpalm; J A Engel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models.

Authors:  Felix M Rivas; James P Stables; Lauren Murphree; Rahul V Edwankar; Chitra R Edwankar; Shengming Huang; Hiteshkumar D Jain; Hao Zhou; Samarpan Majumder; Subramanian Sankar; Bryan L Roth; Joachim Ramerstorfer; Roman Furtmüller; Werner Sieghart; James M Cook
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

5.  Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

Authors:  H E Molewijk; A M van der Poel; J Mos; J A van der Heyden; B Olivier
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

6.  Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats.

Authors:  Laurent B Nicolas; Steffen Klein; Eric P Prinssen
Journal:  Psychopharmacology (Berl)       Date:  2007-06-23       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.